Oral and Gastrointestinal
Defining microbial predictors of responsiveness to biologic therapies in Crohn’s disease and ulcerative colitis (IBD-RESPONSE)
Crohn's disease and ulcerative colitis (UC) are types of a bowel condition known as inflammatory bowel disease (IBD) and the symptoms (diarrhoea, pain, fatigue) have a major impact on daily life. IBD affects around 1 in 125 people in the UK and this is expected to rise to 1 in 100 by 2028. "Biologics" are powerful medications that are given to reduce inflammation in IBD. These treatments can be effective but up to 40% of patients don't respond, and in ...
GO TO STUDY